Literature DB >> 20015406

Hepatitis G virus infection in Egyptian children with chronic renal failure (single centre study).

Ayman Mohammad Hammad1, Mohammad Hosam El Deen Zaghloul.   

Abstract

BACKGROUND: Hepatitis G virus (HGV) is an RNA virus. It is mainly transmitted through exposure to contaminated blood although other routes may also exist. Patients with chronic renal failure (CRF) are at high risk of acquiring HGV because they require frequent blood transfusions. Ongoing HGV infection can be only diagnosed by demonstrating viremia in patient sample by reverse transcriptase (RT) PCR. Antibodies to the envelop protein E2 (anti E2) of HGV is an indicator of virus clearance and testify past HGV contact. This cross sectional study was done to assess the frequency of HGV exposure (ongoing and past infection) in Egyptian children with CRF and to study the possible risk factors of infection.
METHODS: This study included 100 children with CRF [34 on regular haemodialysis (HD) and 66 before the start of dialysis (predialysis)]. All patients sera were tested for HGV RNA by RT-PCR, anti E2, hepatitis C virus (HCV) antibody, hepatitis B surface antigen (HBsAg), and hepatitis B core antibody (HBcAB). Twenty five healthy children of matched age & sex were used as controls.
RESULTS: HGV RNA was positive in 9 (26.5%) of HD and 9 (13.6%) of predialysis children. Anti E2 was positive in 14 (41.2%) of HD and 19 (28.8%) of predialysis children.In comparison to controls; CRF (n = 100); HD and predialysis children had significantly higher prevalence of anti E2 [4% VS 33% for all CRF cases; (p = 0.002)&amp; 41.2% (p = 0.002) and 28.8% (p = 0.01); for HD and predialysis groups; respectively]. HGV RNA was significantly more prevalent only in HD children in comparison to controls (p = 0.03). HD and predialysis children did not have significant difference in the prevalence of HGV RNA (p = 0.16) or anti E2 (p = 0.26).HGV exposure was not correlated with positivity of anti HCV (p = 0.32), HCV RNA (0.09), HBsAg/HBcAB (p = 1), age (p = 0.06), or gender (p = 0.83). It was significantly correlated with duration of the disease (p < 0.001). Ongoing HGV infection was significantly more prevalent with frequent blood transfusion (p < 0.001). There were no significant differences in serum levels of ALT (p = 0.09), total bilirubin (p = 0.1) and albumin (p = 0.06) in children with ongoing infection in comparison to healthy controls.
CONCLUSIONS: The frequency of HGV exposure in Egyptian children with CRF appears to be high and is mainly related to frequent blood transfusions and longer disease duration. HGV infection in these children is not associated with significant changes in hepatic biochemical parameters.

Entities:  

Mesh:

Year:  2009        PMID: 20015406      PMCID: PMC2804678          DOI: 10.1186/1476-0711-8-36

Source DB:  PubMed          Journal:  Ann Clin Microbiol Antimicrob        ISSN: 1476-0711            Impact factor:   3.944


  51 in total

1.  Infection with GB virus C and hepatitis C virus in hemodialysis patients and blood donors in Beijing.

Authors:  Y Wang; H S Chen; M H Fan; H L Liu; P An; N Sawada; T Tanaka; F Tsuda; H Okamoto
Journal:  J Med Virol       Date:  1997-05       Impact factor: 2.327

2.  A cross-sectional study on HGV infection in a rural population.

Authors:  Bin-Hua Ling; Hui Zhuang; Yi-Hui Cui; Wen-Feng An; Zhi-Jie Li; Shu-Ping Wang; Wan-Fu Zhu
Journal:  World J Gastroenterol       Date:  1998-12       Impact factor: 5.742

3.  Prevalence of hepatitis C and G virus infection in chronic hemodialysis patients.

Authors:  M de Medina; M Ashby; V Schlüter; M Hill; B Leclerq; J P Pennell; L J Jeffers; K R Reddy; E R Schiff; G Hess; G O Perez
Journal:  Am J Kidney Dis       Date:  1998-02       Impact factor: 8.860

4.  Detection of hepatitis G virus (HGV) RNA: clinical characteristics of acute HGV infection.

Authors:  T L Yashina; M O Favorov; Y E Khudyakov; H A Fields; O O Znoiko; T V Shkurko; T Bonafonte; J S Sevall; M S Agopian; J B Peter
Journal:  J Infect Dis       Date:  1997-06       Impact factor: 5.226

5.  Prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma.

Authors:  A Arican; T Sengezer; M Bozdayi; H Bozkaya; E Uçgül; D Dinçol; O Uzunalimoğlu
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

6.  Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients.

Authors:  W K Roth; D Waschk; S Marx; S Tschauder; S Zeuzem; H Bialleck; H Weber; E Seifried
Journal:  Transfusion       Date:  1997-06       Impact factor: 3.157

7.  Hepatitis G virus infection in chronic dialysis patients and kidney transplant recipients.

Authors:  F Fabrizi; G Lunghi; G Bacchini; M Corti; I Guarnori; L Raffaele; G Erba; A Pagano; F Locatelli
Journal:  Nephrol Dial Transplant       Date:  1997-08       Impact factor: 5.992

8.  Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection.

Authors:  L D Moaven; S A Locarnini; D S Bowden; J P Kim; A Breschkin; R McCaw; A Yun; J Wages; B Jones; P Angus
Journal:  J Hepatol       Date:  1997-10       Impact factor: 25.083

9.  GB virus C/hepatitis G virus infection in Indian blood donors and high-risk groups.

Authors:  Mayura M Desai; Ramprasad B Pal; Dushyant D Banker
Journal:  Transfus Apher Sci       Date:  2004-04       Impact factor: 1.764

10.  Infection with hepatitis GB virus C in patients on maintenance hemodialysis.

Authors:  K Masuko; T Mitsui; K Iwano; C Yamazaki; K Okuda; T Meguro; N Murayama; T Inoue; F Tsuda; H Okamoto; Y Miyakawa; M Mayumi
Journal:  N Engl J Med       Date:  1996-06-06       Impact factor: 91.245

View more
  11 in total

Review 1.  GBV-C: state of the art and future prospects.

Authors:  Maria Teresa Maidana Giret; Esper Georges Kallas
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

Review 2.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  Screening of febrile patients with suspected malaria from the Brazilian Amazon for virus infection.

Authors:  Marcus Vinícius Guimarães Lacerda; Victor Hugo Aquino; Mario Luis Garcia de Figueiredo; Evan P Williams; Colleen B Jonsson; Mohd Jaseem Khan; Márcio Roberto Teixeira Nunes; Clayton Pereira Silva de Lima; Luiz Tadeu Moraes Figueiredo; Mônica Regina Farias Costa; Maria Paula Gomes Mourão
Journal:  Arch Virol       Date:  2022-07-16       Impact factor: 2.685

Review 4.  The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis.

Authors:  Yousra A Mohamoud; Ghina R Mumtaz; Suzanne Riome; Dewolfe Miller; Laith J Abu-Raddad
Journal:  BMC Infect Dis       Date:  2013-06-24       Impact factor: 3.090

5.  Prevalence, incidence density, and genotype distribution of GB virus C infection in a cohort of recently HIV-1-infected subjects in Sao Paulo, Brazil.

Authors:  Maria Teresa M Giret; João Luiz Miraglia; Maria Cecília Araripe Sucupira; Anna Nishiya; José Eduardo Levi; Ricardo S Diaz; Ester C Sabino; Esper G Kallas
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

6.  Association between Hepatitis G and Unknown Chronic Hepatitis.

Authors:  Saeed Soleiman-Meigooni; Ali Asgari; Seyyed Javad Hoseini-Shokouh; Jalil Rajabi; Mohammad Hassan Kazemi-Galougahi; Mohammad Moshtaghi
Journal:  Electron Physician       Date:  2015-03-01

7.  GB virus C Viremia and Anti-E2 Antibody Response Among Hemodialysis Patients in Gorgan, Iran.

Authors:  Mishar Kelishadi; Mohammad Mojerloo; Abdolvahab Moradi; Masoud Bazouri; Pezhman Hashemi; Sobhan Samadi; Atefeh Saeedi; Alijan Tabarraei
Journal:  Jundishapur J Microbiol       Date:  2014-11-01       Impact factor: 0.747

8.  Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa.

Authors:  Issoufou Tao; Cyrille Bisseye; Bolni Marius Nagalo; Mahamoudou Sanou; Alice Kiba; Guzin Surat; Tegwindé Rebeca Compaoré; Lassina Traoré; Jean Baptiste Nikiema; Virginio Pietra; Jean-Didier Zongo; Jacques Simpore
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

9.  End Stage Renal Disease: Seroprevalence of Hepatitises B and C along with Associated Aetiology and Risk Factors in Children.

Authors:  Syed Raza Shah; Muhammad Shahzeb Khan; Muhammad Tanveer Alam; Adnan Salim; Mehwish Hussain; Areeba Altaf
Journal:  J Trop Med       Date:  2015-08-05

10.  Seroepidemiology of hepatitis B and C viruses in the general population of burkina faso.

Authors:  Issoufou Tao; Tegwindé R Compaoré; Birama Diarra; Florencia Djigma; Theodora M Zohoncon; Maléki Assih; Djeneba Ouermi; Virginio Pietra; Simplice D Karou; Jacques Simpore
Journal:  Hepat Res Treat       Date:  2014-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.